Anonymous
Guest
Anonymous
Guest
All the top finical analyst say Amarin has barely enough money to year end. Read Yahoo it’s not the competition GSK lying it’s fact, Joe and Amarin are broke and there are no buyers
All the top finical analyst say Amarin has barely enough money to year end. Read Yahoo it’s not the competition GSK lying it’s fact, Joe and Amarin are broke and there are no buyers
All the top finical analyst say Amarin has barely enough money to year end. Read Yahoo it’s not the competition GSK lying it’s fact, Joe and Amarin are broke and there are no buyers
This was said by a few analyst if sales did not materialize. They have cash coming in the door now from sales and supply costs are decreasing.
Enough cash to buy a few happy meals and that is about it. That should last a week or so.
Rick, stop talking.
Sales are increasing week over week and more insurances are now covering at Tier 2. Some of the insurances are already covering Trigs > 200 including Tricare. Slow and steady will get us there.
Rick is the best as they come. He just has to deal with the mad man Joe Z
Vascepa is clearly a superior product. Period end of story. The rest is not Important.we developed a better product, it will eventually be the standard.
Then why is the launch well behind the forecast and the stock price suck??
Vascepa is clearly a superior product. Period end of story. The rest is not Important.we developed a better product, it will eventually be the standard.
You stupid idiot!!! People got layoff calls Fri...fat lady singing and product loosing to Lov....its over!